Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Arch Gen Psychiatry. 2011 Oct 3;69(2):139–149. doi: 10.1001/archgenpsychiatry.2011.131

Table 1.

Demographic and Clinical Characteristics of Adolescents With MDD and Healthy Controls

Mean (SD) [Range]
All MDD (n = 20) Anhedonic MDD (n = 10) Nonanhedonic MDD (n = 10) Healthy Controls (n = 21)
Characteristic
 Age, y 16.7 (2.7) [12–19] 18.0 (1.9) [14–19]a 15.3 (2.7) [12–19]a 16.2 (1.6) [13–19]
 Sex, No. (%)
  M 8 (40) 4 (40) 4 (40) 6 (32)
  F 12 (60) 6 (60) 6 (60) 15 (68)
 IQ 106.2 (11.3) 109.8 (10.7)a 102.5 (11.2)a 110.0 (11.6)
 Ethnicity, No. (%)
  White 8 (40) 5 (50) 3 (30) 9 (43)
  African American 2 (10) 0 2 (20) 7 (33)
  Hispanic 8 (40) 3 (30) 5 (50) 0
  Asian 0 0 0 3 (14)
  Other 2 (10) 2 (20) 0 2 (10)
Illness history
 Episode duration, mo 11.7 (8.6) [2–36] 13.1 (10.7) [4–36] 10.2 (6.0) [2–21] 0
 No. of episodes 1.4 (0.6) [1–3] 1.6 (0.7) [1–3] 1.2 (0.4) [1–2] 0
 Suicide attempts 0.3 (0.6) [0–2] 0.1 (0.3) [0–1] 0.4 (0.7) [0–2] 0
 Medication naive, No. (%) 15 (75) 6 (60) 9/1 (90) 21 (100)
Medication free, No. (%) 5 (25) 4 (40) 1 (10) 0
 Melancholic subtype, No. (%) 3 (15) 3 (30) 0 0
 CDRS-R score 52.6 (7.5) [38–68] 56.9 (6.9) [43–68]a 48.3 (5.5) [38–58]a 18.8 (1.1) [17–21]
 BDI-II score 30.1 (12.7) [12–51] 31.8 (13.6) [17–51] 28.4 (12.2) [12–47] 2.6 (3.0) [0–10]
 Anhedonia score 7.7 (2.5) [3–11] 8.3 (2.2) [5–11] 7.0 (2.6) [3–11] 1.3 (0.6) [1–3]
Current comorbidity, No. (%)
 ADHD 4 (20) 2 (20) 2 (20) 0
 Any anxiety disorder 11 (55) 6 (60) 5 (50) 0
 GAD 11 (55) 6 (60) 5 (50) 0

Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BDI-II; Beck Depression Inventory, second edition; CDRS-R; Children’s Depression Rating Scale–Revised; GAD, generalized anxiety disorder; MDD, major depressive disorder.

a

Anhedonic and nonanhedonic MDD subgroups differed significantly with respect to age (P = .02), ethnicity, and MDD severity (P = .007).